None listed
Conditions
Interventions
Medical Device, Procedure/Surgery : 1. Intervention Name: Electroacupuncture (EA) treatment (1 session per visit, total of 2 sessions, bilateral Zusanli-Yinlingquan acupoints, continuous wave, 15-minu
Sponsors
Korea Institute of Oriental Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants who meet all of the following inclusion criteria will be selected: 1) Male or female aged 19 to 80 years. 2) Individuals with post-surgical pain due to musculoskeletal disorders, with a Numerical Rating Scale (NRS) score of 4 or higher (Disease codes: S72090, S7221.000.00, S72120.000.00, S7230.000.0, S82120, M166.000.01, M8785.000.09, M8785, M1999, M1999.000.02, M171.000.03). 3) Individuals who understand the purpose of this clinical trial and the necessary procedures, are able to respond to the pain questionnaire, and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Participants will be excluded from this clinical trial if they meet any of the following exclusion criteria: 1) Individuals whose pain is not caused by surgery or whose pain is not related to a musculoskeletal disorder that caused the surgery. 2) Pregnant or breastfeeding women. 3) Individuals who have received acupuncture or electroacupuncture treatment within 7 days prior to the screening visit. 4) Individuals who have participated in or are currently participating in another clinical trial (e.g., drug, acupuncture, electroacupuncture) within 1 month prior to the screening visit, or those who have another surgery scheduled within the next 2 weeks. 5) Individuals with severe fear of acupuncture, electroacupuncture, or transcutaneous nerve stimulation therapy, or those with known hypersensitivity or risk of adverse reactions to these treatments. 6) Individuals with acupuncture sites that include surgical incision areas, those with infection at the surgical site, severe infectious conditions (e.g., cellulitis), malignant skin tumors at the electroacupuncture site, or severe edema due to deep vein thrombosis. 7) Individuals with a history of alcohol addiction, major depressive disorder, schizophrenia, bipolar disorder, or other uncontrolled severe neuropsychiatric disorders. 8) Individuals whom the investigator deems unsuitable for participation in the clinical trial due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain intensity questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain intensity and pain characteristics questionnaire;Pain questionnaire for the past 24 hours;Heart rate variability (HRV) parameters collected from the heart rate variability measurement device.;Pulse diagnostic parameters collected from the pulse measurement device.;Activity data collected from the smart band | — |
Countries
Korea, Republic of
Contacts
Public ContactJin-Hyun Lee
Catholic Kwandong University International St.Mary's Hospital
Outcome results
None listed